%0 Journal Article %T Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy %A Malapelle, Umberto %A Iaccarino, Antonino %A Rossi, Antonio %J Translational Lung Cancer Research %D 2018 %B 2018 %9 %! Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy %K %X Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) represent key targets for specific monoclonal antibody inhibitors, such as pembrolizumab, nivolumab and atezolizumab, currently used in clinical practice for the management of metastatic non-small cell lung cancer (NSCLC) patients (1). %U https://tlcr.amegroups.org/article/view/23598 %P S221-S224 %@ 2226-4477